Skip to main content

Table 1 Patient’s characteristic

From: Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2 V617F allelic burden

 

PegIFNα (n = 25)

Hydroxyurea (n = 7)

Age

57.0

64

Median (range)

(39–86)

(61–77)

Gender

Male/female

14/12

5/2

Diagnosis

PV/ET/ET-MF

18/7/1

5/1/1

JAK2 V617F allelic burden

25.4

60

Median (range)

(1.0–99.2)

(4.54–93.3)

Hematocrit  %

46.9

50.5

Median (range)

(28.7–70)

(33.4–70.2)

WBC ×109/L

8.1

8.0

Median (range)

(2.5–17.3)

(4.3–12.5)

Platelets × 109/L

391

393

Median (range)

(112–1555)

(123–878)